Business Description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
ISIN : CNE1000000W4
Share Class Description:
HKSE:01349: Class HCompare
Compare
Traded in other countries / regions
01349.Hong Kong688505.ChinaFDY.Germany IPO Date
2002-08-13Description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 100 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.11 | |||||
Interest Coverage | 96.39 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 7.71 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.4 | |||||
3-Year EBITDA Growth Rate | -15.6 | |||||
3-Year EPS without NRI Growth Rate | -20.6 | |||||
3-Year Book Growth Rate | 2.6 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.96 | |||||
9-Day RSI | 38.92 | |||||
14-Day RSI | 42.92 | |||||
6-1 Month Momentum % | -23.91 | |||||
12-1 Month Momentum % | -28.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.88 | |||||
Quick Ratio | 3.77 | |||||
Cash Ratio | 2.54 | |||||
Days Inventory | 292.9 | |||||
Days Sales Outstanding | 249.96 | |||||
Days Payable | 57.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.47 | |||||
Dividend Payout Ratio | 0.53 | |||||
3-Year Dividend Growth Rate | -2 | |||||
Forward Dividend Yield % | 5.47 | |||||
5-Year Yield-on-Cost % | 7.24 | |||||
Shareholder Yield % | 5.92 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 92.05 | |||||
Operating Margin % | 19.81 | |||||
Net Margin % | 15.01 | |||||
FCF Margin % | -1.22 | |||||
ROE % | 4.69 | |||||
ROA % | 3.79 | |||||
ROIC % | 12.67 | |||||
ROC (Joel Greenblatt) % | 19.25 | |||||
ROCE % | 4.52 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.57 | |||||
PE Ratio without NRI | 12.43 | |||||
Shiller PE Ratio | 9.94 | |||||
Price-to-Owner-Earnings | 44.75 | |||||
PS Ratio | 2.27 | |||||
PB Ratio | 0.74 | |||||
Price-to-Tangible-Book | 0.76 | |||||
Price-to-Operating-Cash-Flow | 38.92 | |||||
EV-to-EBIT | 36.37 | |||||
EV-to-EBITDA | 36.37 | |||||
EV-to-Revenue | 5.31 | |||||
EV-to-FCF | -435.56 | |||||
Price-to-Projected-FCF | 1.13 | |||||
Price-to-Graham-Number | 0.65 | |||||
Price-to-Net-Current-Asset-Value | 1.26 | |||||
Price-to-Net-Cash | 2.39 | |||||
Earnings Yield (Greenblatt) % | 2.75 | |||||
FCF Yield % | -0.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 795.559 | ||
EPS (TTM) (HK$) | 0.115 | ||
Beta | 0.53 | ||
Volatility % | 22.07 | ||
14-Day RSI | 42.92 | ||
14-Day ATR (HK$) | 0.047276 | ||
20-Day SMA (HK$) | 1.8285 | ||
12-1 Month Momentum % | -28.57 | ||
52-Week Range (HK$) | 1.71 - 2.66 | ||
Shares Outstanding (Mil) | 1,043 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Frequently Asked Questions
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(HKSE:01349)'s stock price today?
The current price of HKSE:01349 is HK$1.79. The 52 week high of HKSE:01349 is HK$2.66 and 52 week low is HK$1.71.
When is next earnings date of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(HKSE:01349)?
The next earnings date of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(HKSE:01349) is .
Does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(HKSE:01349) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(HKSE:01349) is 5.47% (As of Today), Highest Dividend Payout Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(HKSE:01349) was 1.03. The lowest was 0.21. And the median was 0.39. The  Forward Dividend Yield % of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd(HKSE:01349) is 5.47%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |